Trial Profile
A Phase 4, Pilot, Open-label Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2015
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- Sponsors Alkermes plc
- 09 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Sep 2014 New trial record